NCT00265811 Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery Status COMPLETED Phase PHASE3
NCT00254137 Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2
NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00251498 Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00251485 A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00251381 Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. Status UNKNOWN Phase PHASE2
NCT00240682 Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR Status COMPLETED Phase PHASE2
NCT00232505 Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00226941 A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00226239 Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00216203 Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00215722 XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00207155 An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00207116 An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma Status COMPLETED Phase PHASE1
NCT00203931 Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00193453 Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00182715 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00169247 Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation Status COMPLETED Phase PHASE2
NCT00165490 Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer Status COMPLETED Phase PHASE2